Cartalax (20mg)

Description

What is Cartalax?

Cartalax is a short peptide studied for its role in maintaining cartilage and connective tissue homeostasis. In research models, it has been investigated for effects on chondrocyte activity, extracellular matrix (ECM) synthesis, and signaling pathways related to collagen integrity and proteoglycan balance.

Laboratory studies have explored Cartalax in the context of joint health, tissue repair, and the modulation of inflammatory cytokines that influence cartilage turnover. Ongoing research evaluates its potential utility as a model compound for understanding cartilage preservation and degeneration in osteoarthritis‑related pathways.

Due to its small size and targeted research focus, Cartalax offers a useful framework for examining peptide‑based mechanisms involved in cartilage maintenance, ECM remodeling, and joint function.

Cartalax Product Specifications

Specification	Details
Product	Cartalax
Purity	>99% (HPLC Verified)
Form	White lyophilized powder
Solubility	Soluble in sterile water
Storage Conditions	Store in a cool, dry place; refrigerate after reconstitution
Stability	24 months when properly stored

Why Choose BioEdge Research Labs Cartalax?

Research Grade Purity: Verified purity >99% by third-party HPLC analysis.
Secure Packaging: Designed to maintain peptide stability and prevent degradation during shipment and storage.
Rapid Fulfillment: Most orders ship within 24 hours after payment confirmation.
Researcher Support: Expert customer service tailored to licensed research professionals.

Summary of Preclinical Research Findings

Joint & Cartilage Homeostasis

Cartalax has been examined for its influence on cartilage matrix maintenance, including collagen and proteoglycan dynamics that underpin joint integrity in laboratory models.

Tissue Repair & Extracellular Matrix

Preclinical investigations explore support for ECM remodeling processes, with attention to chondrocyte viability, matrix synthesis, and catabolic/anabolic pathway balance.

Inflammation & Cytokine Signaling

Research models assess how peptide exposure may interact with inflammatory mediators (e.g., IL‑1β, TNF‑α) implicated in cartilage breakdown and joint discomfort, informing mechanistic studies on signaling cascades.

Mobility & Functional Outcomes (Models)

Animal and in‑vitro systems are used to evaluate markers tied to joint function, stiffness, and load‑bearing capacity as readouts of cartilage health in controlled research settings.

Osteoarthritis & Degenerative Models

Cartalax is being used to interrogate pathways relevant to degenerative joint conditions, including metalloproteinase activity, oxidative stress, and ECM turnover in osteoarthritis‑related research.

Suggested Areas of Research

• Chondrocyte proliferation, differentiation, and viability
• Type II collagen and proteoglycan synthesis pathways
• MMP/TIMP balance and ECM turnover
• Cytokine‑mediated signaling (e.g., IL‑1β, TNF‑α, NF‑κB)
• Oxidative stress and cartilage matrix preservation
• Osteoarthritis and joint degeneration models
• Combination studies with cartilage/tendon research agents

Handling & Storage Guidelines

• Store lyophilized Cartalax in a cool, dry place
• Refrigerate after reconstitution
• Use sterile laboratory solvents
• Protect from light, heat, and moisture

For Research Use Only

Cartalax is supplied by BioEdge Research Labs exclusively for laboratory testing and in vitro research.

• Not for human or animal use
• Not for medical or diagnostic purposes
• Purchase confirms that the buyer is a qualified researcher, 18 years or older
• All usage must comply with local laws and lab safety guidelines

Summary of References

Cartalax in Stem Cell & Gene Expression Research

• Ashapkin, V. V., Khavinson, V., Shilovsky, G., Linkova, N., Vanuyshin, B. (2020). Gene expression in human mesenchymal stem cell aging cultures: modulation by short peptides. Molecular Biology Reports, 47, 4323–4329. https://link.springer.com/article/10.1007/s11033-020-05506-3
• Mironova, E. S. (2022). Peptides Affect Stem Cell Aging. Lecture PDF summarizing effects of short peptides including Cartalax (AED) on IGF1, TERT, TNKS2, and NFκB expression in aging models. https://www.peptideproduct.nanolv.lv/upload/lecture_peptide_%20affect_stem_cell_aging_Mironova.pdf

Cartalax in Chondrogenic & Cartilage Research

• Linkova, N., Khavinson, V., Diatlova, A., Myakisheva, S., Ryzhak, G. (2023). Peptide Regulation of Chondrogenic Stem Cell Differentiation. International Journal of Molecular Sciences, 24(9):8415. https://pubmed.ncbi.nlm.nih.gov/37176122/

Cartalax in Fibroblast & ECM Aging Models

• Lin’kova, N. S., Drobintseva, A. O., Orlova, O. A., Kuznetsova, E. P., Polyakova, V. O., Kvetnoy, I. M., Khavinson, V. Kh. (2016). Peptide Regulation of Skin Fibroblast Functions during Their Aging In Vitro. Bulletin of Experimental Biology and Medicine, 161, 175–178. https://link.springer.com/article/10.1007/s10517-016-3370-x

Cartalax in Organ/Tissue Models

• Chalisova, N. I., Lin’kova, N. S., Nichik, T. E., Ryzhak, A. P., Dudkov, A. V., Ryzhak, G. A. (2015). Peptide Regulation of Cells Renewal Processes in Kidney Tissue Cultures from Young and Old Animals. Bulletin of Experimental Biology and Medicine, 159, 124–127. https://link.springer.com/article/10.1007/s10517-015-2906-9

Related Polypeptide & Inflammation Biomarker Research (Cartalax)

• Bandrivsky, Y., Bandrivska, O., Malko, N., Posolenyk, L., Vydoinyk, O., Iskiv, M. (2022). The effectiveness of the use of polypeptide drugs and their effect on the metabolic parameters of oral fluid in patients with generalized periodontitis depending on blood type. Pharmacia, 69(2), 429–435. https://pharmacia.pensoft.net/article/82421/

 

BioEdge Research Labs
Precision. Purity. Performance.

At BioEdge, we are committed to providing research professionals with the highest quality peptides on the market. Every compound we supply is manufactured in a cGMP-certified facility, undergoes rigorous third-party testing, and is intended strictly for in vitro or laboratory research use only.